{"product_id":"wegovy-semaglutida-pluma-precargada-2-4-mg-dosis-3ml","title":"Wegovy (Semaglutide) Pre-filled Pen 1.7Mg\/Dose 3Ml","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eAntidiabetics\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eWegovy\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eNovo Nordisk\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eSemaglutide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003ePre-filled Pen 2.4 Mg\/Dose 3Ml\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eNovo Nordisk\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eWegovy (Semaglutide) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with obesity (body mass index [BMI] ≥ 30 kg\/m²) or overweight (BMI ≥ 27 kg\/m²) who have at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia). This medication acts as a GLP-1 receptor agonist, promoting satiety, decreasing appetite, and reducing food intake. Its use must be supervised by a physician and accompanied by a comprehensive weight management program.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Wegovy pre-filled pen contains Semaglutide as the active ingredient. Additionally, it contains excipients that ensure the product's stability and efficacy. It is important to read the leaflet to know all the components.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eWegovy is contraindicated in patients with a history of hypersensitivity to Semaglutide or any of the excipients. It should not be used in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 syndrome (MEN 2). It is also contraindicated in patients with type 1 diabetes or diabetic ketoacidosis.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of pancreatitis, kidney disease, or those taking other medications that may affect glycemic control. Regular medical follow-up is essential to assess treatment response and adjust the dose if necessary.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eWegovy should be stored in a refrigerator between 2 °C and 8 °C. Do not freeze. The pre-filled pen can be used for up to 28 days at room temperature (not above 30 °C) after being removed from the refrigerator.\u003c\/p\u003e\n\n\u003cp\u003eConsult your doctor\u003c\/p\u003e\n\u003cp\u003ePrescription required.\u003c\/p\u003e","brand":"Novo Nordisk","offers":[{"title":"Default Title","offer_id":46340262035681,"sku":"7503007822970","price":7926.62,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/Wegovy_Semaglutida_Pluma_Precargada_2.4_Mg_Dosis_3Ml_-_7503007822970.png?v=1747095527","url":"https:\/\/wecarepharma.mx\/en\/products\/wegovy-semaglutida-pluma-precargada-2-4-mg-dosis-3ml","provider":"WeCare Pharma","version":"1.0","type":"link"}